Functional Network Analysis Reveals Versatile MicroRNAs in Human Heart

Cellular Physiology and Biochemistry

Volumn 36, Issue 4, 2015, Pages 1628-1643

  Xu, Yingqi ^a   Zhu, Wenliang ^a   Sun, Yong ^a   Wang, Zhe ^a   Yuan, Wei ^a   Du, Zhimin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Heart failure; MicroRNA; MicroRNA 7; Myocardial infarction

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 16; MICRORNA 2; MICRORNA 7; UNCLASSIFIED DRUG; MIRN1 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CONTROLLED STUDY; DYNAMIC PERTURBATION SIMULATION; GENE CONTROL; GENE OVEREXPRESSION; HEART; HEART CONTRACTION; HEART FAILURE; HEART INFARCTION; HUMAN; HUMAN TISSUE; HYPERGEOMETRIC TEST; MALE; MATHEMATICAL ANALYSIS; MOLECULAR DYNAMICS; NETWORK BASED FUNCTIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA ANALYSIS; ANIMAL; CARDIAC MUSCLE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; METABOLISM; MOUSE; PATHOLOGY;

MUS;

ANIMALS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HEART FAILURE; HUMANS; MALE; MICE; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTEIN INTERACTION MAPS;

EID: 84936976600     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430324     Document Type: Article

References (57)

1. Asli NS, Pitulescu ME, Kessel M: MicroRNAs in Organogenesis and Disease. Curr Mol Med 2008;8:698-710.
2. Pan ZW, Lu YJ, Yang BF: MicroRNAs: A novel class of potential therapeutic targets for cardiovascular diseases. Acta Pharmacol Sin 2010;31:1-9.
3. Small EM, Olson EN: Pervasive roles of microRNAs in cardiovascular biology. Nature 2011;469: 336-342.
4. Wang L, Cui Y, Tang M, Hu X, Luo H, Hescheler J, Xi J: Puerarin facilitates T-tubule development of murine embryonic stem cell-derived cardiomyocytes. Cell Physiol Biochem 2014;34:383-92.
5. Li M, Hu X, Zhu J, Zhu C, Zhu S, Liu X, Xu J, Han S, Yu Z: Overexpression of MIR-19b impairs cardiac development in zebrafish by targeting ctnnb1. Cell Physiol Biochem 2014;33:1988-2002.
6. Ning B, Qi X, Li Y, Liu H, Zhang F, Qin C: Biventricular pacing cardiac contractility modulation improves cardiac contractile function via upregulating SERCA2 and MIR-133 in a rabbit model of congestive heart failure. Cell Physiol Biochem 2014;33:1389-99.
7. Tu Y, Wan L, Bu L, Zhao D, Dong D, Huang T, Cheng Z, Shen B: MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: A new mechanism for antihypertrophic intervention. Cell Physiol Biochem 2013;31:997-100
8. Elmén J, Lindow M, Schütz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjärn M, Hansen HF, Berger U, Gullans S, Kearney P, Sarnow P, Straarup EM, Kauppinen S: LNA-mediated microRNA silencing in nonhuman primates. Nature 2008;452:896-899.
9. Diez D, Wheelock AM, Goto S, Haeggström JZ, Paulsson-Berne G, Hansson GK, Hedin U, Gabrielsen A, Wheelock CE: The use of network analyses for elucidating mechanisms in cardiovascular disease. Mol Biosyst 2010;6:289-304.
10. Pillai RS, Bhattacharyya SN, Filipowicz W: Repression of protein synthesis by miRNAs: how many mechanisms. Trends Cell Biol 2007;17:118-126.
11. Naeem H, Küffner R, Csaba G, Zimmer R: miRSel: Automated extraction of associations between microRNAs and genes from the biomedical literature. BMC Bioinformatics 2010;11:135.
12. Van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN: A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006;28:18255-18260.
13. Ikeda S, Pu WT: Expression and Function of MicroRNAs in Heart Disease. Curr Drug Targets 2010;11:913-925.
14. Naga Prasad SV, Duan ZH, Gupta MK, Surampudi VS, Volinia S, Calin GA, Liu CG, Kotwal A, Moravec CS, Starling RC, Perez DM, Sen S, Wu Q, Plow EF, Croce CM, Karnik S: Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem 2009;284:27487-27499.
15. Bostjancic E, Zidar N, Glavac D: MicroRNA microarray expression profiling in human myocardial infarction. Dis Markers 2009;27:255-268.
16. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D: Lifetime risk for developing congestive heart failure: The Framingham Heart study. Circulation 2002;106:3068-3072.
17. Bruford EA, Lush MJ, Wright MW, Sneddon TP, Povey S, Birney E: The HGNC Database in 2008: A resource for the human genome. Nucleic Acids Res 2008;36:D445-D448.
18. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-2504.
19. Martin A, Ochagavia ME, Rabasa LC, Miranda J, Fernandez-de-Cossio J, Bringas R: BisoGenet: A new tool for gene network building, visualization and analysis. BMC Bioinformatics 2010;11:91.
20. Yang L, Walker JR, Hogenesch JB, Thomas RS: NetAtlas: A Cytoscape plugin to examine signaling networks based on tissue gene expression. In Silico Biol 2008;8:47-52.
21. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A, Balakrishnan L, Marimuthu A, Banerjee S, Somanathan DS, Sebastian A, Rani S, Ray S, Harrys Kishore CJ, Kanth S, Ahmed M, Kashyap MK, Mohmood R, Ramachandra YL, Krishna V, Rahiman BA, Mohan S, Ranganathan P, Ramabadran S, Chaerkady R, Pandey A: Human Protein Reference Database-2009 update. Nucleic Acids Res 2009;37:D767-D772.
22. Yassen A, Fidel R, Sven-Eric S, Thomas L, Mario A: Computing topological parameters of biological networks. Bioinformatics 2008;24:282-284.
23. Naeem H, Küffner R, Csaba G, Zimmer R: miRSel: Automated extraction of associations between microRNAs and genes from the biomedical literature. BMC Bioinformatics 2010;11:135.
24. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T: miRecords: An integrated resource for microRNA-target interactions. Nucleic Acids Res 2009;37:D105-110.
25. Sam GJ, Harpreet KS, Stijn van D, Anton J: Enright miRBase: Tools for microRNA genomics. Nucleic Acids Res 2008;36:154-158.
26. Lall S, Grün D, Krek A, Chen K, Wang YL, Dewey CN, Sood P, Colombo T, Bray N, Macmenamin P, Kao HL, Gunsalus KC, Pachter L, Piano F, Rajewsky N: A genome-wide map of conserved microRNA targets in C. elegans. Curr Biol 2006;16:460-471.
27. Friedman RC, Farh KK, Burge CB, Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009;19:92-105.
28. Zhu W, Yang L, Shan H, Zhang Y, Zhou R, Su Z, Du Z: Clinical Advantage of Propranolol Reveals Key MicroRNAs in Myocardial Infarction. PLoS One 2011;6:e14736.
29. Barabási AL, Oltvai ZN: Network biology: understanding the cell's functional organization. Nat Rev Genet 2009;5:101-113.
30. Anyela C, Francisco A: Linking Gene Expression and Functional Network Data in Human Heart Failure. PLoS ONE 2007;2:e1347.
31. Maslov S, Ispolatov I: Propagation of large concentration changes in reversible protein-binding networks. Proc Natl Acad Sci USA 2007;104:13655-13660.
32. Li F, Li P, Xu W, Peng Y, Bo X, Wang S: PerturbationAnalyzer: A tool for investigating the effects of concentration perturbation on protein interaction networks. Bioinformatics 2010;26:275-277.
33. Da WH, Brad TS, Richard AL: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
34. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-5121.
35. Yu W, Wulf A, Liu T, Khoury MJ, Gwinn M: Gene Prospector: An evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases. BMC Bioinformatics 2008;9:528.
36. Reimand J, Arak T, Vilo J: g:Profiler - A web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res 2011;39:W307-W315.
37. Hsu SD, Tseng YT, Shrestha S, Lin YL, Khaleel A, Chou CH, Chu CF, Huang HY, Lin CM, Ho SY, Jian TY, Lin FM, Chang TH, Weng SL, Liao KW, Liao IE, Liu CC, Huang HD: miRTarBase update 2014: An information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res 2014;42:D78-D85.
38. Liu H, Liu W, Liao Y, Cheng L, Liu Q, Ren X, Shi L, Tu X, Wang QK, Guo AY: CADgene: A comprehensive database for coronary artery disease genes. Nucleic Acids Res 2011;39:D991-D996.
39. Finnerty JR, Wang WX, Hébert SS, Wilfred BR, Mao G, Nelson PT: The MIR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J Mol Biol 2010;402:491-509.
40. Jazbutyte V, Thum T: MicroRNA-21: from cancer to cardiovascular disease. Curr Drug Targets 2010;11:926-935.
41. Baek D, Villén J, Shin C, Camargo FD, Gygi SP, Bartel DP: The impact of microRNAs on protein output. Nature 2008;455:64-71.
42. Arvey A, Larsson E, Sander C, Leslie CS, Marks DS: Target mRNA abundance dilutes microRNA and siRNA activity. Mol Syst Bio 2010;6:363.
43. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, Purow B: microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 2008;68:3566-3572.
44. Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ: Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J Biol Chem 2009;284:5731-5741.
45. Li X, Cassidy JJ, Reinke CA, Fischboeck S, Carthew RW: A microRNA imparts robustness against environmental fluctuation during development. Cell 2009;137:273-282.
46. Divakaran V, Mann DL: The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 2008;103:1072-1083.
47. Eapen Z, Rogers JG: Strategies to attenuate pathological remodeling in heart failure. Curr Opin Cardiol 2009;24:223-229.
48. Larsen JA, Kadish AH, Schwartz JB: Proper use of antiarrhythmic therapy for reduction of mortality after myocardial infarction. Drugs Aging 2000;16:341-350
49. Maslov S, Sneppen K: Specificity and stability in topology of protein networks. Science 2002;296: 910-913.
50. Yang B, Lu Y, Wang Z: Control of cardiac excitability by microRNAs. Cardiovasc Res 2008;79: 571-580.
51. Lu Y, Zhang Y, Shan H, Pan Z, Li X: MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: A new mechanism for ischaemic cardioprotection. Cardiovasc Res 2009;84:434-441.
52. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M: MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007;100:416-424.
53. Bonci D,:MicroRNA-21 as therapeutic target in cancer and cardiovascular disease. Recent Pat Cardiovasc Drug Discov 2010;5:156-161.
54. Ghaemmaghami S, Huh WK, Bower K, Howson RW, Belle A, Dephoure N, O'Shea EK, Weissman JS: Global analysis of protein expression in yeast. Nature 2003;425:737-741.
55. Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N: Widespread changes in protein synthesis induced by microRNAs. Nature 2008;455:58-63.
56. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D: MIR-145 and MIR-143 regulate smooth muscle cell fate and plasticity. Nature 2009;460:705-710.
57. Tang WH, Francis GS: The year in heart failure. J Am Coll Cardiol 2010;55:688-696.